Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment

Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment

Lung cancers, the number one cancer killer, can be broadly divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC being the most commonly diagnosed type. Anticancer agents for NSCLC suffer from various limitations that can be partly overcome by the application...

Full description

Bibliographic Details
Main Authors: Noratiqah Mohtar, Thaigarajan Parumasivam, Amirah Mohd Gazzali, Chu Shan Tan, Mei Lan Tan, Rozana Othman, Siti Sarah Fazalul Rahiman, Habibah A. Wahab
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
non-small cell lung cancer
drug delivery
nanoparticles
pulmonary
cellular uptake
permeability
Online Access:https://www.mdpi.com/2072-6694/13/14/3539

Internet

https://www.mdpi.com/2072-6694/13/14/3539

Similar Items